eli lilly tirzepatide news today recency 3 Eli Lilly H1 2025: Tirzepatide Drives 41% Revenue Surge as 4 Clinical Programs Get the Axe Eli Lilly sues Mochi Health

Studies Show Weight Loss Drug Tirzepatide Could Help Patients with Sleep Apnea The popular weight loss and Type 2 diabetes medication tirzepatide, known as Zepbound and Mounjaro, may potentially be the first approved pharmaceutical treatment for people with moderate-to-severe obstructive sleep apnea (OSA) by early 2025

One often overlooked aspect of semaglutide is how it improves your bodys metabolic efficiency

Meanwhile, peptides that influence sexual wellness and vascular function, such as PT-141 (Bremelanotide) and Kisspeptin-10 , are being used to restore vitality and emotional health without relying solely on hormonal replacement therapies

3 Market & Clinical Implications Rybelsus dual approval for glycemic control and CV protection reinforces the GLP-1 mechanism as a cornerstone of modern cardiometabolic medicine